Floatz logo

SFX-01 (SULFORAPHANE STABILIZED WITH .ALPHA. CYCLODEXTRIN)

Anthracycline Related Cardiotoxicity in Breast Cancer

Texas Tech University Health Sciences CenterSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Anthracycline Related Cardiotoxicity in Breast Cancer cohort.

Asset / SponsorPhaseRating
Rosuvastatin
Shiraz University of Medical Sciences
Phase 4BB
Dapagliflozin
University Medical Centre Ljubljana
Phase 2CCC
Sotagliflozin
Icahn School of Medicine at Mount Sinai
Phase 2CCC
Allo-Mscs
The University of Texas Health Science Center, Houston
Phase 1CC

Same molecule, other indications

SFX-01 (SULFORAPHANE STABILIZED WITH .ALPHA. CYCLODEXTRIN) is also rated in:

HIV infectious diseaseDormant
B
Indicative ·
62 / 100
View asset →
breast neoplasmDormant
B
Indicative ·
57 / 100
View asset →
prostate cancerDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →